Susceptibility-weighted imaging in grading brain astrocytomas.
about
Clinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a reviewEmerging Techniques in Brain Tumor Imaging: What Radiologists Need to KnowAn attempt toward objective assessment of brain tumor vascularization using susceptibility weighted imaging and dedicated computer program - a preliminary studyQuantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.Primary central nervous system lymphoma: is absence of intratumoral hemorrhage a characteristic finding on MRI?Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational statusSusceptibility Imaging in Glial Tumor Grading; Using 3 Tesla Magnetic Resonance (MR) System and 32 Channel Head Coil.MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Intracranial Infectious and Inflammatory Diseases Presenting as Neurosurgical Pathologies.Relationship between deep medullary veins in susceptibility-weighted imaging and ipsilateral cerebrovascular reactivity of middle cerebral artery in patients with ischemic stroke.Discriminating pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors by means of susceptibility-weighted imaging.Benefits of contrast-enhanced SWI in patients with glioblastoma multiforme.Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.Variations of ITSS-Morphology and their Relationship to Location and Tumor Volume in Patients with Glioblastoma.Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?Cortical hemosiderin is associated with seizures in patients with newly diagnosed malignant brain tumors.Computational Fractal-Based Analysis of MR Susceptibility-Weighted Imaging (SWI) in Neuro-oncology and Neurotraumatology
P2860
Q26864367-00E7DA27-71B6-40C3-B1E6-CE3FCD924F1AQ28068259-D010BA5B-C7A6-4804-B257-54D9111E5DCCQ28703865-625C0FA6-94ED-4C05-8F6E-C27F95E974FFQ34650241-A6A9EC68-D3EA-4681-A372-34B1591908D4Q35296992-EA13B861-4433-4CF8-BF37-FEB3C7044FFAQ35317072-63B3BF99-D027-40FB-AC6C-B0D6F14D2120Q37677994-F1D09084-E931-4D4D-9D2E-8617DA42085CQ38821879-FE9821E9-F404-470E-B1C8-A4411CB07478Q39312420-19BF45A5-84A3-4A82-87FE-78B82770FEF3Q39346455-D5B11181-8D89-4AE2-8CC8-2C004A3B1E4BQ40381424-73DA1728-5092-4B6A-8644-6D998A5E65FBQ41623893-1238DA35-2A08-4E76-AE6B-4E59A415B522Q45987467-944A9C49-5183-40F9-B4FE-43C8E8851149Q47393298-091A018A-A64E-410D-BED4-EB4A0791821CQ48316997-0D8CC8B0-5FF6-4FF4-9530-3398F354EC1CQ48662054-1A8B9A23-866D-442D-83C1-414109999709Q48843625-00F7ED4B-2CBF-4547-B5F3-41A87A856DDBQ49019720-F1918E07-90EE-45CC-A86C-DF75FCF1FF69Q57773586-B9FB4B79-E194-48E9-9AF7-785197442E4D
P2860
Susceptibility-weighted imaging in grading brain astrocytomas.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Susceptibility-weighted imaging in grading brain astrocytomas.
@en
Susceptibility-weighted imaging in grading brain astrocytomas.
@nl
type
label
Susceptibility-weighted imaging in grading brain astrocytomas.
@en
Susceptibility-weighted imaging in grading brain astrocytomas.
@nl
prefLabel
Susceptibility-weighted imaging in grading brain astrocytomas.
@en
Susceptibility-weighted imaging in grading brain astrocytomas.
@nl
P2093
P1476
Susceptibility-weighted imaging in grading brain astrocytomas.
@en
P2093
P356
10.1016/J.EJRAD.2009.08.003
P577
2009-09-01T00:00:00Z